Transplantation Proceedings
Volume 39, Issue 10 , Pages 2937-2950 , December 2007

Proliferation Signal Inhibitors in Transplantation: Questions at the Cutting Edge of Everolimus Therapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Authors received an honorarium for attending The PSI Forum “Proliferation signal inhibitors in transplantation: questions at the cutting edge,” held in Basel in May 2006, which was fully funded by Novartis Pharma AG.

PII: S0041-1345(07)01150-5

doi: 10.1016/j.transproceed.2007.09.008

Transplantation Proceedings
Volume 39, Issue 10 , Pages 2937-2950 , December 2007

Article Tools

* Image Usage & Resolution